News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Catabasis Pharmaceuticals, Inc. Promotes Michael Curtis, Ph.D., to Senior Vice President, Product Development and Regulatory Affairs



11/2/2011 8:28:47 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, a biopharmaceutical company leveraging the therapeutic potential of omega-3 fatty acids to create therapeutics for the treatment of inflammatory and metabolic diseases, today announced that Michael Curtis, Ph.D., has been promoted to senior vice president, product development and regulatory affairs. In his new position, Dr. Curtis will be responsible for chemistry, manufacturing and controls functions, toxicology, and regulatory approvals. He will continue to be responsible for leading the company’s product development strategy.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES